I am a gastrointestinal pathologist interested in cancer genetics with a strong focus on pancreatic cancer. I am also a member of the David M. Rubenstein Center for Pancreatic Cancer Research. My research interests include understanding the role of somatic mutations in DNA, the “genetic blueprint” of all living cells, in tumorigenesis, metastasis and treatment resistance. I am also the Director of the Medical Donation Program. Unlike traditional body donation or organ donation programs, the Medical Donation Program empowers MSK patients at their end of life to donate their cancer tissues to ongoing state of the art clinical research at Memorial Sloan Kettering Cancer Center.
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more